Efficacy & safety of baclofen to reduce alcohol use in veterans with HCV

功效

• 批准号: 7920237
• 负责人: Peter Hauser
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-10-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7920237
• 关键词: Abstinence; Acceleration; Address; Adherence; Adverse effects; Affect; Agonist; Alanine Transaminase; Albumins; Alcohol abuse; Alcohol consumption; Alcohol dependence; Alcohols; Antiviral Agents; Antiviral Therapy; Appointment; Aspartate Transaminase; Baclofen; Behavior; Bilirubin; Blood Urea Nitrogen; Cessation of life; Chronic Hepatitis C; Cirrhosis; Clinic; Clinic Visits; Communication; Creatinine; Double-Blind Method; Effectiveness; Enrollment; Enzymes; FDA approved; General Population; Glucuronides; Health Personnel; Healthcare; Heavy Drinking; Hepatic; Hepatitis; Hepatitis C; Hepatitis C virus; Kidney; Liver; Liver Function Tests; Liver diseases; Measures; Medical center; Minority; Outcome Measure; Participant; Patient Self-Report; Patients; Pharmaceutical Preparations; Placebo Control; Placebos; Prevalence; Primary carcinoma of the liver cells; Randomized; Recruitment Activity; Reporting; Research Infrastructure; Resources; Risk; Safety; Sampling; Secondary to; Site; Staging; Substance Use Disorder; Time; Veterans; Viral; Woman; alcohol abstinence; alcohol craving; alcohol use disorder; carbohydrate-deficient transferrin; craving; drinking; effective therapy; gamma-Aminobutyric Acid; liver function; liver metabolism; liver transplantation; meetings; men; nervous system disorder; placebo controlled study; primary outcome; receptor; reduced alcohol use; standard of care